Department of Urology, Hacettepe University School of Medicine, 06230, Ankara, Turkey.
Int J Clin Oncol. 2017 Oct;22(5):964-971. doi: 10.1007/s10147-017-1150-x. Epub 2017 Jun 9.
To determine preoperative serum complete blood count parameters that affects survival of patients who underwent surgery for upper urinary tract urothelial cancer (UUT-UC).
Since 1990, 150 patients underwent nephroureterectomy with bladder cuff excision for UUT-UC at Hacettepe University. Patients with a history of muscle-invasive bladder cancer, adjuvant chemotherapy or metastasis at the time of diagnosis were excluded. One hundred and thirteen patients without infective symptoms and with a full set of serum data were evaluated retrospectively. Effects of the neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), platelet-lymphocyte ratio (PLR), and leukocyte count on disease-free survival (DFS) and progression-free survival (PFS) were investigated. Threshold values for each parameter to predict PFS were calculated.
The mean age and median follow-up were 63.7 ± 11.1 years and 34 (3-186) months, respectively. Male to female ratio was 86/27. The 5-years PFS (bladder recurrence was excluded) and DFS were 59.6 and 38.4%, respectively. In multivariate analysis, NLR was independent prognostic factor for PFS and DFS (p = 0.006 and p = 0.021, respectively) while LMR was prognostic only for PFS (p = 0.037).
For UUT-UC, NLR is a prognostic factor for PFS and DFS, while LMR is a prognostic indicator for PFS in present series.
确定影响接受上尿路尿路上皮癌(UUT-UC)手术患者生存的术前血清全血细胞计数参数。
自 1990 年以来,150 例患者在哈塞特佩大学接受了肾输尿管切除术和膀胱袖状切除术治疗 UUT-UC。排除了有肌层浸润性膀胱癌病史、诊断时辅助化疗或转移的患者。回顾性评估了 113 例无感染症状且全套血清数据的患者。研究中性粒细胞与淋巴细胞比值(NLR)、淋巴细胞与单核细胞比值(LMR)、血小板与淋巴细胞比值(PLR)和白细胞计数对无病生存(DFS)和无进展生存(PFS)的影响。计算了每个参数预测 PFS 的临界值。
平均年龄和中位随访时间分别为 63.7±11.1 岁和 34(3-186)个月。男女比例为 86/27。5 年 PFS(排除膀胱复发)和 DFS 分别为 59.6%和 38.4%。多因素分析显示,NLR 是 PFS 和 DFS 的独立预后因素(p=0.006 和 p=0.021),而 LMR 仅对 PFS 有预后意义(p=0.037)。
对于 UUT-UC,NLR 是 PFS 和 DFS 的预后因素,而 LMR 是本研究中 PFS 的预后指标。